tert-Butyl 2-(trifluoromethyl)acrylate, 97%, 250mg

4-Acetamido-2,2,6,6-tetramethylpiperidine 1-Oxyl Free Radical [Catalyst for Oxidation]>98.0%(GC)25g

2-Hydroxy-4-nitrobenzaldehyde, 98.0%, 10g

2-Fluoro-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine, 95.0%, 5g

N-(5-tert-butyl-3-isoxazolyl)-2-chloroacetamide, 95.0%, 5g

(R)-1-Methyl-5-oxopyrrolidine-2-carboxylic acid, 97.0%, 5g

AURANTIO-OBTUSIN, 95%, 100mg

Ethyl 5-benzyl-5,6,7,8-tetrahydro-4H-pyrazolo[1,5-a][1,4]diazepine-7-carboxylate, 97%, 1g

Microliter syringe MICROLITER® series 700 Point type 3, 10 µl, 701 NR, 1 piece

(S)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-2-(4-hydroxyphenyl)acetic acid, 98%, 500mg

1-[(oxolan-2-yl)methyl]-1,4-diazepane, 95.0%, 1g

3-(4-Bromophenyl)-1,1,1-trifluoro-2-propanone, 97.0%, 1g

3,3-Dimethylisoindolin-1-one, 95.0%, 5g